Application progress of food and medicine homologous substances mainly for anti-cancer in the adverse reactions of precision therapies for lung cancer
ZHANG Jing
LI Ruolan
GAO Wei
DU Yan
ZHU Ruifang
Abstract：This review summarizes the common adverse reactions in precision treatment of lung cancer and the research progress on medicinal and food homologous substances (such as lily, ganoderma, ginseng, poria, etc.) with anti-cancer effects in alleviating and managing these adverse reactions. It aims to provide a basis for further exploration of the mechanisms of traditional Chinese medicine and medicinal and food homologous substances in preventing and reducing adverse reactions, and to offer new ideas for clinical workers in managing patients with lung cancer.
Keywords：lung cancerfood and medicine homologousimmunotherapytargeted therapyreviewnursing
Publication Date：2025-08-25
Online Publishing Date：2025-08-28(First online date of this platform, not the publication date of the document)
Pages：5( 3309-3313 )